JAZZ:NASDAQ
Jazz Pharmaceuticals PLC
209,65 USD
arrow_downward
-0,35%(-0,74) 1 d.
209,65 USD
0,00% (0,00)
bedtimePo uzavretí
Zavreté: 14. 10., 16:00:01 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre JAZZ…
Otvoriť
210,34 USD
Vysoká
215,66 USD
Nízka
209,36 USD
Trh. kap.
13,61 mld.
Priem. obj.
791,77 tis.
Objem
0,00
Pomer cena/zárobky
14,33
Max. za 52 týž.
266,38 USD
Min. za 52 týž.
128,80 USD
Výnosy na akciu
14,63 USD
Beta
0,37
Akcie v obehu
64,92 mil.
Počet zamestnancov
3 tis.
Otvoriť
210,34 USD
Vysoká
215,66 USD
Nízka
209,36 USD
Trh. kap.
13,61 mld.
Priem. obj.
791,77 tis.
Objem
0,00
Pomer cena/zárobky
14,33
Max. za 52 týž.
266,38 USD
Min. za 52 týž.
128,80 USD
Výnosy na akciu
14,63 USD
Beta
0,37
Akcie v obehu
64,92 mil.
Počet zamestnancov
3 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Benzinga
·
pred 2 dňami
Jim Cramer Gives Green Light To This Health Care Stock
https://www.dars.gov.et/
·
pred 2 mesiacmi
Jazz Pharmaceuticals (JAZZ) Holds Steady at $256.52 as Shares Trade Flat - FRAMA Signal
Profil
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid. In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness in narcolepsy as well as obstructive sleep apnea. In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America. Wikipedia
Informácie o subjekte Jazz Pharmaceuticals PLC
Generálny riaditeľBruce C Cozadd
Zamestnanci2,89 tis.
Dátum založenia2003
Hlavné sídlo-
Odvetvie-